Drug Development

Articles

The new reagents are designed to support clinical-phase and commercialization stages of cell and gene therapy production and to enhance DNA transfection.

New Reagents Optimize Biologics Production

AbbVie and immunotherapy company Tizona Therapeutics will join forces to develop and commercialize CD39-targeted therapeutics to treat cancer.

AbbVie, Tizona to Develop Antibody Immunotherapy

The company has brought a second stream of high-throughput GMP peptide manufacturing online.

Almac Group Increases Peptide Manufacturing

Yasvanth Ashokraj works in Integrated Product Development at CIPLA.

Prashant Modak works in Integrated Product Development at CIPLA.

Kalpesh Sawant work in Integrated Product Development at CIPLA.

Praveen Date works in Integrated Product Development at CIPLA.

Swati Laud works in Integrated Product Development at CIPLA.

This article demonstrates how qualitative physical attributes testing can be used to characterize soft gel capsule rupture/disintegration during rectal administration.

Evaluating a New Quality Control Test for Soft Gelatin Rectal Capsules

Felicity Thomas is the former Associate Editorial Director of Pharmaceutical Technology, Pharmaceutical Technology Europe, BioPharm International.

New approaches seek to address formulation and delivery challenges for these complex molecules.

Considering Protein and Peptide Delivery

Teva Pharmaceuticals and Neos Therapeutics entered into a settlement and licensing agreement to resolve all ongoing litigation involving Neos' patents protecting its Cotempla (methylphenidate) extended-release orally disintegrating tablets.

Neos Therapeutics, Teva Settle on Patent Litigation for ADHD Drug

Agilent and other partners are funding development of Tapestri, a single-cell sequencing platform designed to help predict cancer relapse in individual patients and show the efficacy of gene-editing experiments.

Investors Raise $30 Million to Advance “Quality Control” for Gene Editing and Relapse Prediction for Oncology

The use of artificial intelligence creates growth opportunities in novel therapeutics development by leveraging multi-sourced data, according to experts at research and consulting firm Frost & Sullivan.

AI Enables Smart Drug Discovery Solutions

The company’s biosimiliar to Roche’s Avastin (bevacizumab) received a positive opinion for marketing authorization from the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP).

Pfizer Receives Positive CHMP Opinion for Avastin Biosimilar

Avacta Group and LC Chem Life Sciences have entered into a multi-target collaboration and development agreement.

Formulation and Drug Delivery